ProPhase Labs, Inc.

PRPH · OTC · SIC 2834: Pharmaceutical Preparations
471
SEC Filings

Business Summary

ProPhase Labs, Inc. is a diversified biotech, genomics, and consumer products company. It offers whole genome sequencing through Nebula Genomics and DNA Complete, develops novel drugs and dietary supplements via ProPhase BioPharma (PBIO), markets TK Supplements dietary supplements, and previously provided COVID-19 PCR and antigen diagnostic testing. The company also owns worldwide exclusive rights to the BE-Smart Esophageal Pre-Cancer diagnostic screening test.

Next Earnings

Q2 FY2026 — expected 2026-09-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPRPHdiscussed_in_filing Cybersecurity
topic_mentionPRPHdiscussed_in_filing Trusted Computing
topic_mentionPRPHdiscussed_in_filing Blockchain & Crypto
topic_mentionPRPHdiscussed_in_filing Capital Expenditure
topic_mentionPRPHdiscussed_in_filing Supply Chain
topic_mentionPRPHdiscussed_in_filing Regulation
topic_mentionPRPHdiscussed_in_filing Healthcare & Bio
topic_mentionPRPHdiscussed_in_filing Platform & Ecosystem
topic_mentionPRPHdiscussed_in_filing Sovereign & Government
topic_mentionPRPHdiscussed_in_filing Cybersecurity
topic_mentionPRPHdiscussed_in_filing Trusted Computing
topic_mentionPRPHdiscussed_in_filing Blockchain & Crypto
topic_mentionPRPHdiscussed_in_filing Capital Expenditure
topic_mentionPRPHdiscussed_in_filing Supply Chain
topic_mentionPRPHdiscussed_in_filing Regulation
topic_mentionPRPHdiscussed_in_filing Healthcare & Bio
topic_mentionPRPHdiscussed_in_filing Platform & Ecosystem
topic_mentionPRPHdiscussed_in_filing Sovereign & Government
topic_mentionPRPHdiscussed_in_filing Cybersecurity
topic_mentionPRPHdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-04-012024-12-310000868278-25-000003EDGAR73K words
2024-03-292023-12-310000868278-24-000004EDGAR—
2023-03-292022-12-310000868278-23-000004EDGAR—
2022-03-312021-12-310001493152-22-008541EDGAR—
2021-03-312020-12-310001493152-21-007538EDGAR—
2020-03-262019-12-310001493152-20-004807EDGAR—
2019-03-262018-12-310001493152-19-003946EDGAR—
2018-03-282017-12-310001493152-18-004041EDGAR—
2017-02-242016-12-310001493152-17-001890EDGAR—
2016-03-292015-12-310001493152-16-008343EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-192025-09-300000868278-25-000017EDGAR34K words
2025-08-132025-06-300000868278-25-000011EDGAR—
2025-05-202025-03-310000868278-25-000007EDGAR—
2024-11-132024-09-300000868278-24-000014EDGAR—
2024-08-142024-06-300000868278-24-000010EDGAR—
2024-05-102024-03-310000868278-24-000007EDGAR—
2023-11-132023-09-300000868278-23-000017EDGAR—
2023-08-112023-06-300000868278-23-000014EDGAR—
2023-05-122023-03-310000868278-23-000008EDGAR—
2022-11-102022-09-300001493152-22-031384EDGAR—
2022-08-122022-06-300001493152-22-022350EDGAR—
2022-05-132022-03-310001493152-22-013346EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-130001493152-26-006784EDGAR1K words
2026-02-130001493152-26-006785EDGAR—
2026-01-270001493152-26-003724EDGAR—
2026-01-230001493152-26-003460EDGAR—
2026-01-230001493152-26-003456EDGAR—
2026-01-090001493152-26-001143EDGAR—
2026-01-090001493152-26-001134EDGAR—
2026-01-020001493152-26-000175EDGAR—
2025-12-190001493152-25-028537EDGAR—
2025-12-190001493152-25-028483EDGAR—

471 total filings indexed. 439 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

personal-genomics diagnostics dietary-supplements drug-development esophageal-cancer-screening middle-east-and-north-africa-(mena) clia-(clinical-laboratory-improvement-amendments) fda-laboratory-developed-test-(ldt)-regulations pcr-(polymerase-chain-reaction)

Company Identity

CIK0000868278
TickerPRPH
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersOld Bridge, New Jersey

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 0ae54501e1b59200ddb380c94f6e8634c5016ae5c9940a8d82c00de6a112c130
parent: 73524572ceaeaa82b472ecf0afa53425edeffca7e3402b2a9c3655cc6fb0600a
content hash: 9277645c836519abccbb4d42acef892c641dcb1b77c69a4a093ff1ef9eaedfb0
signed: 2026-04-13T04:47:00.600Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf